Working... Menu

A Double-Blinded Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986020 Versus Placebo in Diffuse Cutaneous Systemic Sclerosis (dcSSc)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02588625
Recruitment Status : Withdrawn
First Posted : October 28, 2015
Last Update Posted : July 22, 2016
Information provided by (Responsible Party):
Bristol-Myers Squibb

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : October 2019
  Estimated Study Completion Date : October 2019